Skip to main content

ERAS

Stock
Health Care
Biotechnology

Performance overview

ERAS Price
Price Chart

Forward-looking statistics

Beta
0.89
Risk
70.66%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.

Company info

SectorHealth Care
IndustryBiotechnology
Employees130
Market cap$647.9M

Fundamentals

Enterprise value$106.0M
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity12.72

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.57
Dividend per share
Revenue per share$0.00
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$2M
Put-call ratio

Macro factor sensitivity

Growth-3.1
Credit+8.9
Liquidity+2.1
Inflation-9.1
Commodities-3.2
Interest Rates-2.0

Valuation

Dividend yield0.00%
PEG Ratio-1.95
Price to sales
P/E Ratio-1.95
Enterprise Value to Revenue
Price to book1.02

Upcoming events

Next earnings dayMay 14, 2025
Next dividend day
Ex. dividend day

News

Down -25.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Erasca (ERAS)

Erasca (ERAS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Investment Research (January 21, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free